MarketsTrump’s 25% Tariff Jolts India's Export Sectors, But Pain May Be Short-LivedBY Vaibhavi Ranjan
Economy & PolicyTrump Tariff on Indian Goods Could Raise Cost of Essential Drugs in US: PharmexcilBY PTI
MarketsTrump Tariff Fallout: Textile, IT, Pharma, Auto Ancillary Stocks Take a HitBY Outlook Business Desk
Economy & PolicyIndia-US Trade Deal: Policy Experts See 'Strategic Opportunity' in Trump’s 25% Tariff ShockBY Outlook Business Desk
